<DOC>
	<DOCNO>NCT00537654</DOCNO>
	<brief_summary>This study open-label , randomize , single dose , three way partial crossover study healthy male subject . The aim study evaluate bioequivalence fix dose combination ( FDC ) capsule dutasteride tamsulosin hydrochloride ( HCl ) ( 0.5 milligram [ mg ] /0.4 mg ) relative co-administration dutasteride 0.5 mg capsule tamsulosin hydrochloride 0.4 mg tablet feed fasted state . Approximately 98 healthy adult male subject enrol study . Subjects receive single oral dos 3 treatment period randomize one twelve different treatment sequence ( ABC , ACB , BAC , BCA , CAB , CBA , ABD , ADB , BAD , BDA , DAB , DBA ) wherein A= commercially available tamsulosin hydrochloride 0.4 mg dutasteride 0.5 mg fed state , B= fix dose combination formulation dutasteride tamsulosin hydrochloride ( 0.5 mg dutasteride , 0.4 mg tamsulosin hydrochloride ) fed state , C= commercially available tamsulosin hydrochloride 0.4 mg dutasteride 0.5 mg fast state , D= fix dose combination formulation dutasteride tamsulosin hydrochloride ( 0.5 mg dutasteride , 0.4 mg tamsulosin hydrochloride ) fast state . Each treatment period separate minimum 28 day washout period . The total duration subject 's involvement study approximately 15-18 week .</brief_summary>
	<brief_title>A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State</brief_title>
	<detailed_description>An Open-Label , Randomized , Single Dose Three-Period Partial Crossover Study Determine Bioequivalence Food Effect Combination Capsule Formulation Dutasteride Tamsulosin Hydrochloride ( 0.5mg/0.4mg ) Compared Concomitant Dosing AVODART 0.5mg FLOMAX 0.4mg Commercial Capsules Healthy Male Subjects</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Dutasteride</mesh_term>
	<criteria>Inclusion criterion : Healthy subject define individual free clinically significant illness disease determine investigator base medical history , physical examination , laboratory study , ECGs , test . Males 18 45 year age , inclusive . Weight range 55 95 kg ( inclusive ) body mass index 19 30 kg/m2 ( inclusive ) . Willing able give write informed consent , willing participate full duration study , able understand follow instruction relate study procedure Exclusion criterion : Slow metabolizer CYP2D6 determine screen PGx analysis . History postural hypotension , dizziness , poor hydration , vertigo , vasovagal reaction sign symptom orthostasis , opinion investigator could exacerbate tamsulosin result put subject risk injury . Use prescription nonprescription drug , include vitamin , herbal dietary supplement within 7 day ( 14 day drug potential enzyme inducer , St. John 's Wort ) 5 halflives ( whichever longer ) prior first dose study medication , unless opinion investigator sponsor medication interfere study procedure compromise subject safety . Chronic hepatitis B C , evidence positive Hepatitis B surface antigen ( HBsAg ) Hepatitis C antibody . Positive HIV test screening . History sensitivity heparin heparininduced thrombocytopenia . History regular alcohol consumption exceed 14 drinks/week men ( 1 drink = 5 ounce wine 12 ounce beer 1.5 ounce hard liquor ) within 6 month screen . Subjects must able willing abstain beverage foods contain alcohol 24 hour prior dose day . A positive urine drug alcohol ( Breath test urine ) screen result screen checkin.. The subject receive investigational drug participate research trial within 30 day 5 halflives , twice duration biological effect drug ( whichever longer ) prior first dose current study medication anytime study period . Where participation study would result donation blood excess 500 mL within 56 day period . History presence allergy , intolerance , contraindication tamsulosin HCl AVODART drug class , history drug allergy ( include true sulfonamide allergy ) , opinion physician responsible , contraindicate participation . Subjects consume follow food drink within 7 day prior first dose study medication time clinical phase study : grapefruit juice ; red wine ; grapefruit cruciferous vegetable ( watercress , broccoli , cabbage , Brussels sprout ) . QTc â‰¥ 450 msec screening .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>benign prostatic hyperplasia ,</keyword>
	<keyword>AVODART ,</keyword>
	<keyword>FLOMAX</keyword>
</DOC>